8,284 results on '"Supuran, Claudiu T."'
Search Results
302. Cysteine-Modifying Agents: A Possible Approach for Effective Anticancer and Antiviral Drugs
303. Structure activity study of carbonic anhydrase IX: Selective inhibition with ureido-substituted benzenesulfonamides
304. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII
305. Inhibition of Malassezia globosa carbonic anhydrase with phenols
306. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs
307. Evaluation of selenide, diselenide and selenoheterocycle derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors
308. Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties
309. Supported ionic liquid membranes immobilized with carbonic anhydrases for CO2 transport at high temperatures
310. Geographical characterization by MAE-HPLC and NIR methodologies and carbonic anhydrase inhibition of Saffron components
311. Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects
312. Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data
313. Comparison of the anion inhibition profiles of the β- and γ-carbonic anhydrases from the pathogenic bacterium Burkholderia pseudomallei
314. Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds
315. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets
316. Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators
317. Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors
318. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties
319. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies
320. New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs
321. Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors
322. Dithiocarbamates effectively inhibit the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa
323. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations
324. Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity
325. Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics
326. Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695
327. Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase‑B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction.
328. Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains.
329. 1,2,3‐Triazole‐based esters and carboxylic acids as nonclassical carbonic anhydrase inhibitors capable of cathepsin B inhibition.
330. Synthetic Approaches to Novel Human Carbonic Anhydrase Isoform Inhibitors Based on Pyrrol-2-one Moiety.
331. Carbonic anhydrase, its inhibitors and vascular function.
332. Novel sulfonamide‐phosphonate conjugates as carbonic anhydrase isozymes inhibitors.
333. Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma.
334. Leveraging SARS-CoV-2 Main Protease (M pro) for COVID-19 Mitigation with Selenium-Based Inhibitors.
335. Novel Drug Screening Assay for Acanthamoeba castellanii and the Anti-Amoebic Effect of Carbonic Anhydrase Inhibitors.
336. Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity.
337. Chapter 1 - Introduction to metalloenzymes: From bench to bedside
338. Chapter 3.9 - CD73 (5′-Ectonucleotidase)
339. Chapter 2.7 - Paraoxonases
340. Chapter 3.1 - Carbonic anhydrases
341. Chapter 3.3 - Bacterial zinc proteases
342. New Biological Targets for the Treatment of Leishmaniasis
343. Therapeutic Use of Carbonic Anhydrase Inhibitors and Their Multiple Drug Interactions
344. Carbonic anhydrase activators and their potential in the pharmaceutical field
345. Carbonic anhydrase inhibitors as diuretics
346. List of contributors
347. Mechanism of action of carbonic anhydrase inhibitors
348. Carbonic Anhydrase Inhibitor—NO Donor Hybrids and Their Pharmacological Applications
349. Carbonic anhydrase inhibitors for the treatment of neuropathic pain and arthritis
350. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.